Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03327220 · ClinicalTrials.gov registry record · NA
Treatment With Iovera° for Total Knee Arthroplasty (TKA) Post-Operative Pain
A NA study, sponsored by Pacira Pharmaceuticals.
- Completed
- Registry status
- NA
- Development phase
- 124
- Enrollment target
NCT03327220 is a NA study that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 124 participants.
The verdict
NCT03327220, a NA study, has completed, sponsored by Pacira Pharmaceuticals.
- COMPLETED
- Registry status
- NA
- Development phase
- 124 participants
- Enrollment target
Study Summary
This study is designed to investigate whether iovera° treatment prior to TKA decreases cumulative participant opioid use over the course of 6 weeks following TKA while maintaining similar levels of pain relief. The study will also investigate whether there is a relationship between participants treated with iovera° and participant reported pain and function as measured by knee injury and osteoarthritis outcomes score (KOOS JR), numeric rating scale (NRS) for pain; use of hospital services post-TKA and improved physical rehabilitation as measured by range of motion.
Interventions
- DEVICE iovera°
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2017-11-06 |
| Est. Completion | 2019-03-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03327220
The ClinicalTrials.gov registry entry for NCT03327220 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pacira Pharmaceuticals, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which iovera° is the first listed.
NCT03327220 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03327220 about?
NCT03327220 is a clinical study titled "Treatment With Iovera° for Total Knee Arthroplasty (TKA) Post-Operative Pain". This study is designed to investigate whether iovera° treatment prior to TKA decreases cumulative participant opioid use over the course of 6 weeks following TKA while maintaining similar levels of pain relief. The study will also investigate whether there is a relationship between participants trea...
What is the current status of trial NCT03327220?
This trial is currently completed. It is a NA study. The enrollment target is 124 participants. The study started on 2017-11-06. Estimated completion is 2019-03-27.
What interventions are being tested in trial NCT03327220?
The interventions under investigation include: iovera° (DEVICE).
Who is sponsoring clinical trial NCT03327220?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.